Skip to content

NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE      HIV • HCV • STIs • SUBSTANCE USE • LGBT HEALTH

HIVQUAL • CEI TRAINING

  • JOIN OUR MAIL LIST
  • ABOUT US
  • POCKET GUIDES & SLIDES
  • HOME

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • HIV Testing and Acute HIV
  • HIV Treatment
  • PEP and PrEP
  • Hepatitis Care
  • Primary and Specialty HIV Care
  • HPV-Related Cancer Prevention
  • Sexual Health
  • Perinatal HIV Prevention
  • Substance Use

NYCDOHMH: COVID-19 Vaccine Updates: Johnson & Johnson/Janssen and People Vaccinated Outside the US (5/22/21)

https://www1.nyc.gov/assets/doh/downloads/pdf/covid/providers/covid-19-providers-dear-colleague-updates-05212021.pdf

Post navigation

Previous Previous post: Updated Guideline: Prevention and Management of Hepatitis A Virus in Adults With HIV (5/21/21)
Next Next post: Updated: Use of Dolutegravir in Individuals of Childbearing Capacity (6/3/21)

This website is managed by the Clinical Guidelines Program in the JHU School of Medicine, Division of Infectious Diseases, on behalf of the NYSDOH AIDS Institute. 1550 Orleans Street, CRB II, Office 1M11, Baltimore, MD 21287-0014

Quick Links: About | Guideline Development | About the Site | New York State Department of Health | AIDS Institute

Contact us: aiguidelines@jhmi.edu

Copyright © Johns Hopkins University HIV Clinical Guidelines Program 2000-2023. All Rights Reserved.